Buscador de empleo
Encuentre oportunidades en Novartis a continuación.
Aviso para los solicitantes de ofertas de empleo de EE.UU. Saber más
Showing 549 results
- Sort by Sort ascending
- Título profesional Sort ascending
- Negocio
- Localización
- Sitio
- Fecha de publicación
| Título profesional Sort ascending | Negocio | Localización | Sitio | Fecha de publicación |
|---|---|---|---|---|
| Content Enablement Specialist Regular, Full time | Purchasing & Sourcing | India | Hyderabad (Office) | Dic 02, 2025 |
| Global Clinical Operations- Stratety&Operations Manager Regular, Full time | Development | China +Alternative Locations | Beijing (Beijing) | Dic 02, 2025 |
| Medical Scientific Liaison (Immunology) Regular, Full time | General Management | Taiwan | Taipei | Dic 02, 2025 |
| Senior Specialist DDIT ISC Automation Specialist Regular, Full time | Information Technology | India | Hyderabad (Office) | Dic 02, 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts – Texas Regular, Full time | General Management | Estados Unidos +Alternative Locations | Field Non-Sales (USA) | Dic 02, 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts – Phoenix Regular, Full time | General Management | Estados Unidos +Alternative Locations | Field Non-Sales (USA) | Dic 02, 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts - Pennsylvania Regular, Full time | General Management | Estados Unidos +Alternative Locations | Field Non-Sales (USA) | Dic 02, 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts – Pacific NW Regular, Full time | General Management | Estados Unidos +Alternative Locations | Field Non-Sales (USA) | Dic 02, 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts - Boston, MA Regular, Full time | General Management | Estados Unidos +Alternative Locations | Field Non-Sales (USA) | Dic 02, 2025 |
| Director, Business Excellence Lead, ASCVD Regular, Full time | General Management | Estados Unidos | East Hanover | Dic 02, 2025 |